Prompt, accurate diagnosis of cerebrovascular disease is enhanced at the Geisinger Neurosciences Institute with the use of advanced diagnostic techniques such as:
- MRI, including diffusion-weighted imaging (DW-MRI) and perfusion
- Magnetic resonance angiography (MRA)
- Magnetic resonance spectroscopy (MRS)
- Diamox single-photon emission computed tomography (SPECT)
- Positron Emission tomography (PET)
- High-resolution CT angiography
- Carotid ultrasound
- Transcranial Doppler (TCD)
- Intracranial pressure and cerebral blood-flow monitoring
- Functional MRI
- Computer-assisted cerebral digital subtraction angiography (DSA)
- Access to investigational treatments for acute stroke
An active clinical research program ensures that Geisinger's acute stroke patients have access to new and emerging medical, surgical and diagnostic modalities.
Geisinger specialists, at the forefront of clinical research, have helped pioneer new treatments for cerebral aneurysms, vascular malformations, carotid stenosis, cavernous carotid fistulae and life-threatening brain swelling from strokes.
Surgical and medical therapies for stroke and cerebrovascular diseases include surgery for acute stroke, skull base surgery and circulatory arrest for aneurysm surgery, intravenous and intra-arterial thrombolytic therapy for acute stroke.
In addition, Geisinger specialists are also pioneering intravenous and intra-arterial thrombolysis for ischemic stroke.